5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.58%
Revenue growth 1.25-1.5x VALMT.HE's 9.91%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-2.59%
Negative gross profit growth while VALMT.HE is at 13.08%. Joel Greenblatt would examine cost competitiveness or demand decline.
26.46%
EBIT growth above 1.5x VALMT.HE's 11.84%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
26.46%
Operating income growth above 1.5x VALMT.HE's 11.84%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
29.09%
Net income growth above 1.5x VALMT.HE's 12.28%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-25.81%
Negative EPS growth while VALMT.HE is at 13.16%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.81%
Negative diluted EPS growth while VALMT.HE is at 13.16%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.69%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.69%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
697.62%
OCF growth above 1.5x VALMT.HE's 21.62%. David Dodd would confirm a clear edge in underlying cash generation.
524.12%
FCF growth above 1.5x VALMT.HE's 26.61%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-17.22%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 77.47%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
43.94%
5Y revenue/share CAGR above 1.5x VALMT.HE's 16.33%. David Dodd would look for consistent product or market expansions fueling outperformance.
5.72%
3Y revenue/share CAGR under 50% of VALMT.HE's 14.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
674.87%
10Y OCF/share CAGR under 50% of VALMT.HE's 2115.63%. Michael Burry would worry about a persistent underperformance in cash creation.
761.09%
5Y OCF/share CAGR above 1.5x VALMT.HE's 440.99%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
264.22%
3Y OCF/share CAGR under 50% of VALMT.HE's 6034.51%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
235.29%
Below 50% of VALMT.HE's 4200.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
283.33%
5Y net income/share CAGR above 1.5x VALMT.HE's 104.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
91.67%
3Y net income/share CAGR similar to VALMT.HE's 86.96%. Walter Schloss would attribute it to shared growth factors or demand patterns.
59.17%
10Y equity/share CAGR at 50-75% of VALMT.HE's 81.61%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
69.86%
5Y equity/share CAGR above 1.5x VALMT.HE's 34.85%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
29.41%
3Y equity/share CAGR at 75-90% of VALMT.HE's 38.02%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
67.55%
Below 50% of VALMT.HE's 157.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
22.04%
Below 50% of VALMT.HE's 68.32%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
8.76%
AR growth well above VALMT.HE's 3.48%. Michael Burry fears inflated revenue or higher default risk in the near future.
-5.91%
Inventory is declining while VALMT.HE stands at 7.31%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.40%
Asset growth at 75-90% of VALMT.HE's 3.03%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
7.30%
1.25-1.5x VALMT.HE's 6.46%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-2.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.39%
We cut SG&A while VALMT.HE invests at 8.45%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.